News
The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...
Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.
"With the COVID pandemic behind us, it is time to adopt a common-sense approach to COVID policy," a spokesperson for the FDA ...
1d
MedPage Today on MSNFDA Chief Defends Job Cuts, COVID Booster Policy at Senate HearingSeven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...
FDA Commissioner Dr. Marty Makary and vaccine chief Dr. Vinay Prasad set stricter approval standards for booster shots ...
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of serious illness ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
The rollout of updated Covid vaccines for healthy children and adults this fall is likely to be delayed after the FDA said it ...
Food and Drug Administration Commissioner Marty Makary promised stakeholders last week that the agency’s new Covid-19 vaccine ...
Government advisers are split on whether drugmakers should update their COVID-19 vaccines to better protect Americans this ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results